[Interuniversity report. How and when to combine antihypertensive agents].
作者信息
Rorive G
出版信息
Rev Med Liege. 1982 Feb 1;37(3):73-6.
PMID:6123147
Abstract
摘要
相似文献
1
[Interuniversity report. How and when to combine antihypertensive agents].
Rev Med Liege. 1982 Feb 1;37(3):73-6.
2
[Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent].用丙酰肼（ISF 2123）联合利尿剂和β受体阻滞剂治疗重度动脉高血压
Minerva Cardioangiol. 1979 Mar;27(3):113-8.
3
[Drug therapy for arterial hypertension].[动脉高血压的药物治疗]
Soins. 1982 Feb;27(4):25-35.
4
Evaluation and treatment of the hypertensive patient.高血压患者的评估与治疗。
Prim Care. 1983 Mar;10(1):3-20.
5
Pharmacological basis for combination therapy of hypertension.高血压联合治疗的药理学基础。
Annu Rev Pharmacol Toxicol. 1977;17:311-23. doi: 10.1146/annurev.pa.17.040177.001523.
6
[Calcium antagonists in the treatment of arterial hypertension].[钙拮抗剂在动脉高血压治疗中的应用]
Klin Med (Mosk). 1985 Nov;63(11):9-15.
7
[Basic principles and methods of treating hypertension].[高血压治疗的基本原则和方法]
Vestn Akad Med Nauk SSSR. 1981(9):50-9.
8
[Evaluation of combination drug therapy in the malignant phase of arterial hypertension].[联合药物治疗在动脉高血压恶性期的评估]
Srp Arh Celok Lek. 1983 Jul;111(7):905-18.
9
[Medical treatment of arterial hypertension (author's transl)].动脉高血压的医学治疗（作者译）
Urologe A. 1981 May;20(3):130-4.
10
[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].[固定剂量联合疗法：通过增强耐受性和降压疗效减少副作用]
Rev Esp Cardiol. 1999;52 Suppl 3:59-72.
Zotero 插件